![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » WITH FDA'S NEW OK FOR AVASTIN, GENENTECH SAYS IT WILL CAP PRICE
WITH FDA'S NEW OK FOR AVASTIN, GENENTECH SAYS IT WILL CAP PRICE
Genentech said Wednesday that U.S. regulators approved its cancer drug Avastin in combination with chemotherapy to treat lung cancer. The company also said it would cap the annual cost of the drug to some patients.
San Francisco Business Times (http://www.bizjournals.com/sanfrancisco/stories/2006/10/09/daily37.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct